Disclosure of shareholdings in accordance with Art. 20 SESTA

Santhera Pharmaceuticals (SWX: SANN) was informed by Schroders plc, 31 Gresham Street, London, EC2V 7QA, United Kingdom, that it holds a total of 156,428 registered shares of Santhera Pharmaceuticals Holding AG, representing 5.05 % of the voting rights of the shares registered in the Commercial Register.

For Further Information, Contact
Thomas Staffelbach, VP Public & Investor Relations
Phone: +41 (0)61 906 89 47
thomas.staffelbach@santhera.com